Life Sciences
DOE Methodology for Downstream Purification of pDNA with Ion-Exchange Resins
Join this GEN webinar, sponsored by Thermo Fisher Scientific, our expert panelist will tell us more about a design of experiment (DoE) study to evaluate…
Broadcast Date: February 21, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
The growth of cell and gene therapies and mRNA therapeutics has increased demand for purified, high-quality plasmid DNA (pDNA). However, being quite distinct from traditional protein therapeutics, plasmid production and purification pose unique challenges.
In this GEN webinar, our expert panelist will tell us more about a design of experiment (DoE) study to evaluate and optimize POROS Anion Exchange (AEX) resins for pDNA capture in the downstream process. Dynamic binding capacity (DBC) for a particular pDNA was determined for various POROS AEX resins, as well as optimum process conditions and operating parameters. This methodology can be utilized to evaluate POROS AEX resins for various pDNA downstream purification schemes.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
R&D Manager
Thermo Fisher Scientific
The post DOE Methodology for Downstream Purification of pDNA with Ion-Exchange Resins appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….
